Robot Assisted Upper Limb Neuro-Rehabilitation

This study has been completed.
Sponsor:
Information provided by:
Department of Veterans Affairs
ClinicalTrials.gov Identifier:
NCT00011583
First received: February 22, 2001
Last updated: March 10, 2008
Last verified: March 2008
  Purpose

Our long term objectives are to understand the mechanisms of motor impairment following neurologic injury and to develop interventions to improve motor recovery. A series of complementary, overlapping clinical trials and development activities will validate and optimize the use of robot-assisted upper limb therapy for neuro rehabilitation.

We have developed a robotic system that assists or resists elbow and shoulder movements in three dimensional space. In addition to unilateral exercise modes, a novel bimanual mode enables hemiparetic subjects to practice mirror image upper limb exercises.


Condition Intervention Phase
Acute Stroke
Device: Robot-assisted therapy
Device: Traditional therapy
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Robot Assisted Upper Limb Neuro-Rehabilitation

Resource links provided by NLM:


Further study details as provided by Department of Veterans Affairs:

Primary Outcome Measures:
  • Fugl-Meyer score [ Time Frame: end of training, 6-month follow-up ] [ Designated as safety issue: No ]

Estimated Enrollment: 60
Study Start Date: January 2000
Study Completion Date: December 2003
Primary Completion Date: December 2003 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
1 hour/day of mechanically-assisted upper limb therapy
Device: Robot-assisted therapy
1 hour/day of mechanically-assisted upper limb therapy
Active Comparator: 2
1 hour/day of upper limb therapy that includes exposure to, but no manipulation by the robot
Device: Traditional therapy
1 hour/day of upper limb therapy that includes exposure to, but no manipulation by the robot

Detailed Description:

Randomized controlled clinical trial of the Mirror Image Movement Enabler (MIME) robotic device for shoulder and elbow neurorehabilitation in subacute stroke patients. MIME incorporates a PUMA 560 robot that applies forces to the paretic limb during unilateral and bilateral movements in three dimensions. Robot-assisted treatment (bilateral, unilateral, and combined bilateral and unilateral) was compared with conventional therapy.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Stroke patients

Exclusion Criteria:

Unable to follow instructions; medically unstable.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00011583

Locations
United States, Texas
Central Texas Veterans Health Care System
Temple, Texas, United States, 76504
Sponsors and Collaborators
Investigators
Principal Investigator: Charles Burgar, MD Central Texas Veterans Health Care System
  More Information

No publications provided

Responsible Party: Burgar, Charles - Principal Investigator, Department of Veterans Affairs
ClinicalTrials.gov Identifier: NCT00011583     History of Changes
Other Study ID Numbers: B2156
Study First Received: February 22, 2001
Last Updated: March 10, 2008
Health Authority: United States: Federal Government

Keywords provided by Department of Veterans Affairs:
Cerebrovascular
Hemiplegia
Robotics

Additional relevant MeSH terms:
Stroke
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on August 19, 2014